文献
J-GLOBAL ID:201802293757649937
整理番号:18A0025952
HIV-1感染(ARIA)を用いた未治療女性における固定用量併用ドルテグラビル,アバカビル,ラミブジンとリトナビル追加アタザナビルとテノホビルdisoproxilフマル酸およびエムトリシタビン:無作為化,非盲検,非劣性,第3b相研究からの結果48週【Powered by NICT】
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
著者 (13件):
Orrell Catherine
(Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa)
,
Hagins Debbie P
(Chatham County Health Department, Savannah, GA, USA)
,
Belonosova Elena
(Orel Regional Center for AIDS, Orel, Russia)
,
Porteiro Norma
(Fundacion IDEAA, Buenos Aires, Argentina)
,
Walmsley Sharon
(University Health Network, Toronto, ON, Canada)
,
Falco Vicenc
(Hospital Vall d’Hebron, Barcelona, Spain)
,
Man Choy Y
(ViiV Healthcare, Research Triangle Park, NC, USA)
,
Aylott Alicia
(GlaxoSmithKline, Stockley Park, UK)
,
Buchanan Ann M
(ViiV Healthcare, Research Triangle Park, NC, USA)
,
Wynne Brian
(ViiV Healthcare, Collegeville, PA, USA)
,
Vavro Cindy
(ViiV Healthcare, Research Triangle Park, NC, USA)
,
Aboud Michael
(ViiV Healthcare, Brentford, UK)
,
Smith Kimberly Y
(ViiV Healthcare, Research Triangle Park, NC, USA)
資料名:
Lancet HIV
(Lancet HIV)
巻:
4
号:
12
ページ:
e536-e546
発行年:
2017年
JST資料番号:
W3122A
ISSN:
2352-3018
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)